Evaluation of the Recovery Rate and Postoperative Incontinence of Surgical Fistulas in a Cohort of a Reference Centre
PROFIL
1 other identifier
observational
600
1 country
1
Brief Summary
Fistula is a pathology that can be complex and lead to treatment difficulties for the proctologist. The proctologist's objective is to treat the infection (anal fistula and abscess) with the minimum impact on anal continence. Drainage of the fistula pathway(s) and removal of infected tissue during initial surgery are essential. The treatment of upper trans-sphincterial fistulas, i. e. those that span more than half the height of the anal sphincter, poses risks to anal continence. It sometimes requires several times of surgical treatment. The study aim to investigate the fate of all patients treated for anal fistula in an expert team, in terms of impact on healing and anal continence and according to the type of anal fistula, the co-morbidity, the surgical techniques used and the bacterial flora responsible.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2019
CompletedFirst Submitted
Initial submission to the registry
March 4, 2019
CompletedFirst Posted
Study publicly available on registry
March 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedSeptember 23, 2025
September 1, 2025
7 years
March 4, 2019
September 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Healing rate at 2 years after initial surgical management of anal fistula.
Healing is defined by the absence of anal pain, pus discharge and anal swelling reported by the patient.
2 years
Secondary Outcomes (8)
Anal incontinence rate in participants operated for anal fistula, 2 years after initial care.
Year 2
Healing rate in participants operated for anal fistula, at 6, 12 and 24 months after initial care.
Month 6, 12, 24
Assessment of time to consolidated recovery.
Month 24
Description of the number of surgeries required to obtain a cure.
2 years
Bacteriological profile at the level of the fistula at the time of diagnosis and research into a possible role in the cure rate, the surgical technique used and the rate of post-operative incontinence.
2 weeks
- +3 more secondary outcomes
Study Arms (1)
anal Fistula
patient with anal fistula with indication to surgical treatment
Interventions
A pus sample from the fistula will be taken by the doctor during this first consultation or, failing that, in the operating room before disinfection.
Eligibility Criteria
Patient with an anus fistula with indication for surgical treatment
You may qualify if:
- Patient over the age of 18, patient with an anus fistula with indication for surgical treatment
You may not qualify if:
- Cutaneous Suppuration, without fistula (e.g., Verneuil disease, boil)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Groupe Hospitalier Diaconesses Croix Saint Simon
Paris, 75020, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2019
First Posted
March 7, 2019
Study Start
March 1, 2019
Primary Completion
March 1, 2026
Study Completion
March 1, 2026
Last Updated
September 23, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share